+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anal Cancer Market by Treatment Type, End User, Therapeutic Line, Disease Stage, Administration Mode, Cancer Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Anal Cancer Market by Treatment Type, End User, Therapeutic Line, Disease Stage, Administration Mode, Cancer Type, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Anal Cancer Market by Treatment Type, End User, Therapeutic Line, Disease Stage, Administration Mode, Cancer Type, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967579
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anal cancer market is undergoing significant change, shaped by advances in oncology, evolving epidemiology, and shifting regulatory dynamics. Senior decision-makers must adapt to ongoing innovation and global pressures in order to optimize clinical and business outcomes.

Market Snapshot: Anal Cancer Market Growth and Outlook

The Anal Cancer Market grew from USD 1.06 billion in 2024 to USD 1.13 billion in 2025. It is expected to continue growing at a CAGR of 6.41%, reaching USD 1.54 billion by 2030. This expansion reflects rising incidence rates, increased adoption of advanced therapies, and greater focus on value-driven care delivery worldwide. Competitive activity remains strong as pharmaceutical and medical technology leaders invest in precision therapeutics, digital diagnostics, and collaborative research alliances.

Scope & Segmentation

This report delivers a rigorous breakdown across all major dimensions shaping the anal cancer market:

  • Treatment Type: Chemotherapy (Combination Chemotherapy, Single-Agent Chemotherapy), Combined Modality Therapy (Concurrent Chemoradiotherapy, Sequential Chemoradiotherapy), Immunotherapy (Checkpoint Inhibitors, Vaccine Therapy), Radiotherapy (Brachytherapy, External Beam Radiotherapy), Surgery (Abdominoperineal Resection, Local Excision), Targeted Therapy (EGFR Inhibitors)
  • End User: Ambulatory Surgical Centers, Diagnostic Laboratories (Molecular Diagnostics Laboratories, Pathology Laboratories), Hospitals (Community Hospitals, Tertiary Hospitals), Oncology Centers (Dedicated Cancer Centers, Multi-Specialty Clinics), Specialty Clinics
  • Therapeutic Line: First-Line (Concurrent Chemoradiotherapy, Radiotherapy Alone), Second-Line (Chemotherapy, Immunotherapy, Targeted Therapy), Third-Line And Beyond (Clinical Trials, Palliative Care)
  • Disease Stage: Stage III, Stage IV, Stage I-II
  • Administration Mode: Intravenous, Oral, Topical
  • Cancer Type: Adenocarcinoma, Melanoma, Squamous Cell Carcinoma
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, and others), Asia-Pacific (with China, India, Japan, Australia, and more)
  • Companies: Merck & Co., Inc., Bristol-Myers Squibb Company, Varian Medical Systems, Inc., Elekta AB (publ), Siemens Healthineers AG, General Electric Company, Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Koninklijke Philips N.V.

Key Takeaways for Senior Decision-Makers

  • The anal cancer market is driven by innovation in immunotherapeutic and precision medicine approaches, with organizations differentiating on technology platforms and integrated service offerings.
  • Emerging trends in surgical and radiation techniques emphasize minimally invasive and organ-preserving procedures, supporting better patient experiences and outcomes.
  • Global adoption gaps remain, requiring region-specific strategies that reflect regulatory requirements, access to diagnostics, and health systems’ ability to support advanced treatments.
  • Strategic alliances between pharmaceutical developers, diagnostic firms, and research institutions are accelerating clinical trial pipelines and enabling more agile response to shifting patient needs.
  • Market segmentation analysis reveals diverse patient cohorts, each requiring targeted interventions—from early-stage disease in developed markets to late-stage or high-risk populations in emerging economies.
  • Companies that integrate digital health platforms and data-driven decision-support tools position themselves to capture real-world insights and enhance care delivery.

Tariff Impact: Navigating U.S. Policy Shifts in 2025

Recent U.S. tariff adjustments have introduced new complexities for stakeholders managing therapeutic procurement, medical equipment sourcing, and clinical research inputs. As costs rise for specialty drugs, advanced machinery, and reagents, supply chains are adapting through diversification, domestic partnerships, and inventory strategies. This evolving landscape demands proactive scenario planning, transparent pricing, and collaboration with payers and policymakers to protect access and drive ongoing treatment innovation.

Methodology & Data Sources

This report utilizes a mixed-methods research strategy, combining analysis of peer-reviewed studies, clinical trial databases, and regulatory filings with direct interviews from leading oncologists, researchers, and health system experts. Rigorous validation—through expert panels and iterative reviews—ensures the integrity and relevance of every insight presented.

Why This Report Matters

  • Supports informed investment and operational planning with differentiated segment and region analysis for the anal cancer market.
  • Empowers leadership to identify collaboration opportunities and mitigation strategies in the face of policy and market uncertainty.
  • Facilitates evidence-based decisions by synthesizing real-world trends, regulatory impacts, and technological shifts.

Conclusion

This report equips leaders to navigate the evolving anal cancer landscape with confidence. Combining deep clinical insight and actionable strategic guidance, it enables proactive responses to market, regulatory, and technological change.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of PD-1 and PD-L1 inhibitors in refractory anal squamous cell carcinoma patients
5.2. Expansion of HPV vaccination programs to reduce anal cancer incidence among high risk populations
5.3. Integration of intensity modulated radiation therapy and proton beam therapy for toxicity reduction
5.4. Development of dual checkpoint blockade regimens targeting PD-1 and CTLA-4 in advanced anal cancer
5.5. Adoption of circulating tumor DNA assays for personalized monitoring and early recurrence detection
5.6. Clinical development of targeted therapies against EGFR and PI3K pathway alterations in anal carcinoma
5.7. Expansion of minimally invasive photodynamic therapy and cryoablation for anal intraepithelial neoplasia management
5.8. Growing pipeline of combination immunoradiotherapy clinical trials for improved anal cancer survival outcomes
5.9. Integration of advanced MRI and PET imaging for precise staging and treatment planning in anal cancer
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anal Cancer Market, by Treatment Type
8.1. Introduction
8.2. Chemotherapy
8.2.1. Combination Chemotherapy
8.2.2. Single-Agent Chemotherapy
8.3. Combined Modality Therapy
8.3.1. Concurrent Chemoradiotherapy
8.3.2. Sequential Chemoradiotherapy
8.4. Immunotherapy
8.4.1. Checkpoint Inhibitors
8.4.2. Vaccine Therapy
8.5. Radiotherapy
8.5.1. Brachytherapy
8.5.2. External Beam Radiotherapy
8.6. Surgery
8.6.1. Abdominoperineal Resection
8.6.2. Local Excision
8.7. Targeted Therapy
8.7.1. EGFR Inhibitors
9. Anal Cancer Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Diagnostic Laboratories
9.3.1. Molecular Diagnostics Laboratories
9.3.2. Pathology Laboratories
9.4. Hospitals
9.4.1. Community Hospitals
9.4.2. Tertiary Hospitals
9.5. Oncology Centers
9.5.1. Dedicated Cancer Centers
9.5.2. Multi-Specialty Clinics
9.6. Specialty Clinics
10. Anal Cancer Market, by Therapeutic Line
10.1. Introduction
10.2. First-Line
10.2.1. Concurrent Chemoradiotherapy
10.2.2. Radiotherapy Alone
10.3. Second-Line
10.3.1. Chemotherapy
10.3.2. Immunotherapy
10.3.3. Targeted Therapy
10.4. Third-Line And Beyond
10.4.1. Clinical Trials
10.4.2. Palliative Care
11. Anal Cancer Market, by Disease Stage
11.1. Introduction
11.2. Stage III
11.3. Stage IV
11.4. Stage I-II
12. Anal Cancer Market, by Administration Mode
12.1. Introduction
12.2. Intravenous
12.3. Oral
12.4. Topical
13. Anal Cancer Market, by Cancer Type
13.1. Introduction
13.2. Adenocarcinoma
13.3. Melanoma
13.4. Squamous Cell Carcinoma
14. Anal Cancer Market, by Distribution Channel
14.1. Introduction
14.2. Hospital Pharmacy
14.3. Online Pharmacy
14.4. Retail Pharmacy
15. Americas Anal Cancer Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Anal Cancer Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Anal Cancer Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Merck & Co., Inc.
18.3.2. Bristol-Myers Squibb Company
18.3.3. Varian Medical Systems, Inc.
18.3.4. Elekta AB (publ)
18.3.5. Siemens Healthineers AG
18.3.6. General Electric Company
18.3.7. Pfizer Inc.
18.3.8. GlaxoSmithKline plc
18.3.9. Johnson & Johnson
18.3.10. Koninklijke Philips N.V.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. ANAL CANCER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANAL CANCER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANAL CANCER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANAL CANCER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ANAL CANCER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ANAL CANCER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ANAL CANCER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. ANAL CANCER MARKET: RESEARCHAI
FIGURE 30. ANAL CANCER MARKET: RESEARCHSTATISTICS
FIGURE 31. ANAL CANCER MARKET: RESEARCHCONTACTS
FIGURE 32. ANAL CANCER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANAL CANCER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANAL CANCER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANAL CANCER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANAL CANCER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANAL CANCER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANAL CANCER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANAL CANCER MARKET SIZE, BY COMBINATION CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANAL CANCER MARKET SIZE, BY COMBINATION CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANAL CANCER MARKET SIZE, BY SINGLE-AGENT CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANAL CANCER MARKET SIZE, BY SINGLE-AGENT CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANAL CANCER MARKET SIZE, BY CONCURRENT CHEMORADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANAL CANCER MARKET SIZE, BY CONCURRENT CHEMORADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANAL CANCER MARKET SIZE, BY SEQUENTIAL CHEMORADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANAL CANCER MARKET SIZE, BY SEQUENTIAL CHEMORADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANAL CANCER MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANAL CANCER MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANAL CANCER MARKET SIZE, BY VACCINE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANAL CANCER MARKET SIZE, BY VACCINE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANAL CANCER MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANAL CANCER MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANAL CANCER MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANAL CANCER MARKET SIZE, BY EXTERNAL BEAM RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANAL CANCER MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANAL CANCER MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANAL CANCER MARKET SIZE, BY ABDOMINOPERINEAL RESECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANAL CANCER MARKET SIZE, BY ABDOMINOPERINEAL RESECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANAL CANCER MARKET SIZE, BY LOCAL EXCISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANAL CANCER MARKET SIZE, BY LOCAL EXCISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANAL CANCER MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANAL CANCER MARKET SIZE, BY EGFR INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANAL CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANAL CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANAL CANCER MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANAL CANCER MARKET SIZE, BY MOLECULAR DIAGNOSTICS LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANAL CANCER MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANAL CANCER MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANAL CANCER MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANAL CANCER MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANAL CANCER MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANAL CANCER MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANAL CANCER MARKET SIZE, BY DEDICATED CANCER CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANAL CANCER MARKET SIZE, BY DEDICATED CANCER CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANAL CANCER MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANAL CANCER MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANAL CANCER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANAL CANCER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANAL CANCER MARKET SIZE, BY FIRST-LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANAL CANCER MARKET SIZE, BY FIRST-LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANAL CANCER MARKET SIZE, BY CONCURRENT CHEMORADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANAL CANCER MARKET SIZE, BY CONCURRENT CHEMORADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY ALONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY ALONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL ANAL CANCER MARKET SIZE, BY SECOND-LINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL ANAL CANCER MARKET SIZE, BY SECOND-LINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL ANAL CANCER MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL ANAL CANCER MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL ANAL CANCER MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL ANAL CANCER MARKET SIZE, BY PALLIATIVE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL ANAL CANCER MARKET SIZE, BY STAGE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL ANAL CANCER MARKET SIZE, BY STAGE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL ANAL CANCER MARKET SIZE, BY STAGE IV, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL ANAL CANCER MARKET SIZE, BY STAGE IV, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL ANAL CANCER MARKET SIZE, BY STAGE I-II, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL ANAL CANCER MARKET SIZE, BY STAGE I-II, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL ANAL CANCER MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL ANAL CANCER MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL ANAL CANCER MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL ANAL CANCER MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL ANAL CANCER MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL ANAL CANCER MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL ANAL CANCER MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL ANAL CANCER MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL ANAL CANCER MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL ANAL CANCER MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL ANAL CANCER MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL ANAL CANCER MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL ANAL CANCER MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL ANAL CANCER MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL ANAL CANCER MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL ANAL CANCER MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL ANAL CANCER MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS ANAL CANCER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES ANAL CANCER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 227. CANADA ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 228. CANADA ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 229. CANADA ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 230. CANADA ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 231. CANADA ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 232. CANADA ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 233. CANADA ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 234. CANADA ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 235. CANADA ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 236. CANADA ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 237. CANADA ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 238. CANADA ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 239. CANADA ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 240. CANADA ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 241. CANADA ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. CANADA ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. CANADA ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 244. CANADA ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 245. CANADA ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. CANADA ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. CANADA ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 248. CANADA ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2025-2030 (USD MILLION)
TABLE 249. CANADA ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2018-2024 (USD MILLION)
TABLE 250. CANADA ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2025-2030 (USD MILLION)
TABLE 251. CANADA ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2018-2024 (USD MILLION)
TABLE 252. CANADA ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2025-2030 (USD MILLION)
TABLE 253. CANADA ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2018-2024 (USD MILLION)
TABLE 254. CANADA ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2025-2030 (USD MILLION)
TABLE 255. CANADA ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2018-2024 (USD MILLION)
TABLE 256. CANADA ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2025-2030 (USD MILLION)
TABLE 257. CANADA ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 258. CANADA ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 259. CANADA ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2018-2024 (USD MILLION)
TABLE 260. CANADA ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2025-2030 (USD MILLION)
TABLE 261. CANADA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 262. CANADA ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 263. CANADA ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. CANADA ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. MEXICO ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 268. MEXICO ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 269. MEXICO ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 270. MEXICO ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 271. MEXICO ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 272. MEXICO ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 273. MEXICO ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 274. MEXICO ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 275. MEXICO ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 276. MEXICO ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 277. MEXICO ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 278. MEXICO ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 279. MEXICO ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. MEXICO ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. MEXICO ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 282. MEXICO ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 283. MEXICO ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 284. MEXICO ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 285. MEXICO ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 286. MEXICO ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2025-2030 (USD MILLION)
TABLE 287. MEXICO ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2018-2024 (USD MILLION)
TABLE 292. MEXICO ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2025-2030 (USD MILLION)
TABLE 293. MEXICO ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2018-2024 (USD MILLION)
TABLE 294. MEXICO ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2025-2030 (USD MILLION)
TABLE 295. MEXICO ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 296. MEXICO ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 297. MEXICO ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2018-2024 (USD MILLION)
TABLE 298. MEXICO ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2025-2030 (USD MILLION)
TABLE 299. MEXICO ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 300. MEXICO ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 301. MEXICO ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. MEXICO ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL ANAL CANCER MARKET SIZE, BY THERAPEUTIC LINE, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL ANAL CANCER MARKET SIZE, BY FIRST-LINE, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL ANAL CANCER MARKET SIZE, BY SECOND-LINE, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL ANAL CANCER MARKET SIZE, BY THIRD-LINE AND BEYOND, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2018-2024 (USD MILLION)
TABLE 334. BRAZIL ANAL CANCER MARKET SIZE, BY DISEASE STAGE, 2025-2030 (USD MILLION)
TABLE 335. BRAZIL ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2018-2024 (USD MILLION)
TABLE 336. BRAZIL ANAL CANCER MARKET SIZE, BY ADMINISTRATION MODE, 2025-2030 (USD MILLION)
TABLE 337. BRAZIL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 338. BRAZIL ANAL CANCER MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 339. BRAZIL ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. BRAZIL ANAL CANCER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. ARGENTINA ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 342. ARGENTINA ANAL CANCER MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 343. ARGENTINA ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2018-2024 (USD MILLION)
TABLE 344. ARGENTINA ANAL CANCER MARKET SIZE, BY CHEMOTHERAPY, 2025-2030 (USD MILLION)
TABLE 345. ARGENTINA ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2018-2024 (USD MILLION)
TABLE 346. ARGENTINA ANAL CANCER MARKET SIZE, BY COMBINED MODALITY THERAPY, 2025-2030 (USD MILLION)
TABLE 347. ARGENTINA ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2018-2024 (USD MILLION)
TABLE 348. ARGENTINA ANAL CANCER MARKET SIZE, BY IMMUNOTHERAPY, 2025-2030 (USD MILLION)
TABLE 349. ARGENTINA ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2018-2024 (USD MILLION)
TABLE 350. ARGENTINA ANAL CANCER MARKET SIZE, BY RADIOTHERAPY, 2025-2030 (USD MILLION)
TABLE 351. ARGENTINA ANAL CANCER MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 352. ARGENTINA ANAL CANCER MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 353. ARGENTINA ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2018-2024 (USD MILLION)
TABLE 354. ARGENTINA ANAL CANCER MARKET SIZE, BY TARGETED THERAPY, 2025-2030 (USD MILLION)
TABLE 355. ARGENTINA ANAL CANCER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 356. ARGENTINA ANAL CANCER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 357. ARGENTINA ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 358. ARGENTINA ANAL CANCER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 359. ARGENTINA ANAL CANCER MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 360. ARGENTINA ANAL CANCER MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 361. ARGENTINA ANAL CANCER MARKET SIZE, BY ONCOLOGY CENTERS, 2018-2024 (USD MILLION)
TABLE 362. ARGENTINA ANAL CANCER MARKET S

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Anal Cancer market report include:
  • Merck & Co., Inc.
  • Bristol-Myers Squibb Company
  • Varian Medical Systems, Inc.
  • Elekta AB (publ)
  • Siemens Healthineers AG
  • General Electric Company
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Koninklijke Philips N.V.

Table Information

Report AttributeDetails
No. of Pages180
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.54 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Anal Cancer Epidemiology Forecast 2025-2034 - Product Image

Anal Cancer Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Anal Cancer Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035 - Product Image

Anal Cancer Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035

  • Report
  • Global
From
Anal Cancer - Pipeline Insight, 2025 - Product Image

Anal Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Anus Neoplasms Drug Pipeline Analysis Report 2025 - Product Image

Anus Neoplasms Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Familial Adenomatous Polyposis - Pipeline Insight, 2025 - Product Image

Familial Adenomatous Polyposis - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.